<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Pfizer Inc.</title><link href="http://factsaboutmenopause.com/topic/pfizer-inc" rel="alternate"></link><id>http://factsaboutmenopause.com/topic/pfizer-inc</id><updated>2010-10-27T08:55:02Z</updated><entry><title>Questions over ghostwriting in drug industry</title><link href="http://factsaboutmenopause.com/questions-ghostwriting-drug-industry-1320771a" rel="alternate"></link><updated>2010-09-10T15:45:44Z</updated><author><name>Scientific American</name></author><id>tag:factsaboutmenopause.com,2010-09-10:/questions-ghostwriting-drug-industry-1320771a/</id><summary type="html">...</summary><category term="Trials"></category><category term="Civil Trials"></category><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Menopause"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="The New York Times Company"></category><category term="Washington, DC"></category><category term="New York"></category><category term="Boston"></category><category term="Massachusetts"></category><category term="Women's Health"></category><category term="California State University System"></category><category term="Prempro"></category><category term="Georgetown University Medical Center"></category><category term="Pfizer Inc."></category><category term="Princeton (New Jersey)"></category><category term="Northridge"></category><category term="PLoS Medicine"></category><category term="Adriane Fugh-Berman"></category><category term="Christopher Loder"></category><category term="Leemon McHenry"></category><category term="Thomas Stossel"></category></entry><entry><title>Investment Opportunities in Women's Health</title><link href="http://factsaboutmenopause.com/investment-opportunities-womens-health-3465659a" rel="alternate"></link><updated>2010-10-27T08:55:02Z</updated><author><name>SeekingAlpha</name></author><id>tag:factsaboutmenopause.com,2010-10-27:/investment-opportunities-womens-health-3465659a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Menopause"></category><category term="Medical Technology"></category><category term="Social Issues"></category><category term="Women's Issues"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Food and Drug Administration"></category><category term="Women's Health"></category><category term="Pfizer Inc."></category><category term="Pristiq"></category><category term="Depomed Inc."></category><category term="Carl Pelzel"></category><category term="Bionovo Inc."></category><category term="Isaac Cohen"></category><category term="Robert A. Essner"></category></entry><entry><title>Panel cites benefits of Pfizer osteoporosis drug</title><link href="http://factsaboutmenopause.com/panel-cites-benefits-pfizer-osteoporosis-drug-445384a" rel="alternate"></link><updated>2010-09-01T12:17:39Z</updated><author><name>AP Features</name></author><id>tag:factsaboutmenopause.com,2010-09-01:/panel-cites-benefits-pfizer-osteoporosis-drug-445384a/</id><summary type="html">&lt;div&gt;&lt;p&gt;An experimental drug from &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; could benefit certain women with osteoporosis, federal advisers said Monday, despite concerns of side effects.&lt;/p&gt;&lt;p&gt;A &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; panel of experts voted 9-3 that the benefits of Fablyn could outweigh its risks, including blood clots and vaginal bleeding, for some women. The FDA is not required to f...</summary><category term="Geriatric Medicine"></category><category term="Osteoporosis"></category><category term="Menopause"></category><category term="Wall Street"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="Women's Health"></category><category term="Fosamax"></category><category term="Pfizer Inc."></category><category term="Rodman &amp; Renshaw LLC"></category><category term="Ligand Pharmaceuticals Inc."></category><category term="Scott Monroe"></category><category term="Muscle and Skeletal Health"></category></entry><entry><title>FDA wary of deaths with Pfizer osteoporosis drug</title><link href="http://factsaboutmenopause.com/fda-wary-deaths-pfizer-osteoporosis-drug-441626a" rel="alternate"></link><updated>2010-09-01T12:17:41Z</updated><author><name>AP Features</name></author><id>tag:factsaboutmenopause.com,2010-09-01:/fda-wary-deaths-pfizer-osteoporosis-drug-441626a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Federal regulators say a drug from &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; and &lt;a title="Ligand Pharmaceuticals Inc." href="/topic/Ligand+Pharmaceuticals+Inc." &gt;Ligand Pharmaceuticals&lt;/a&gt; effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies.&lt;/p&gt;&lt;p&gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; noted Thursday that women t...</summary><category term="Vascular Disorders"></category><category term="Geriatric Medicine"></category><category term="Osteoporosis"></category><category term="Menopause"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="Women's Health"></category><category term="Pfizer Inc."></category><category term="Ligand Pharmaceuticals Inc."></category><category term="Jack Cox"></category><category term="Cardiovascular Medicine"></category><category term="Blood Clots and Embolisms"></category><category term="Muscle and Skeletal Health"></category></entry><entry><title>Pfizer Settlement</title><link href="http://factsaboutmenopause.com/photo/pfizer-settlement-1651693p" rel="alternate"></link><updated>2010-04-02T22:51:46Z</updated><author><name>AP News</name></author><id>tag:factsaboutmenopause.com,2010-04-02:/photo/pfizer-settlement-1651693p/</id><summary type="html">&lt;a title="Federal Bureau of Investigation" href="/topic/Federal+Bureau+of+Investigation" &gt;FBI&lt;/a&gt; Assistant Director of Criminal Investigative Division &lt;a title="Kevin Perkins" href="/topic/Kevin+Perkins" &gt;Kevin Perkins&lt;/a&gt;, right, looks on as &lt;a title="Tom Perrelli" href="/topic/Tom+Perrelli" &gt;Associate Attorney General Tom Perrelli&lt;/a&gt;,  answers questions during a news conference to announce &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; will pay a record $2.3 billion civil and c...</summary><category term="Investigations"></category><category term="Criminal Investigations"></category><category term="United States"></category><category term="Federal Bureau of Investigation"></category><category term="Washington, DC"></category><category term="Pfizer Inc."></category><category term="Tom Perrelli"></category><category term="Kevin Perkins"></category></entry><entry><title>Pfizer CEO</title><link href="http://factsaboutmenopause.com/photo/pfizer-ceo-543116p" rel="alternate"></link><updated>2010-04-14T10:37:58Z</updated><author><name>AP News</name></author><id>tag:factsaboutmenopause.com,2010-04-14:/photo/pfizer-ceo-543116p/</id><summary type="html">&lt;a title="Jeffrey Kindler" href="/topic/Jeffrey+Kindler" &gt;Jeffrey Kindler&lt;/a&gt;, chairman and CEO of Pfizer, speaks at a news conference Monday, Jan. 26, 2009, in &lt;a title="New York" href="/topic/New+York" &gt;New York&lt;/a&gt;. Eager to dispel doubts about the difficulties of executing &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer Inc.&lt;/a&gt;'s $68 billion tie-up with Wyeth, Pfizer's CEO said it will be done more like microsurgery than just stitching two huge corporations together. (AP Photo/Mark...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="New York"></category><category term="Pfizer Inc."></category><category term="Jeffrey Kindler"></category></entry><entry><title>Pfizer to acquire Wyeth for $68 billion dollars</title><link href="http://factsaboutmenopause.com/photo/pfizer-acquire-wyeth-68-billion-dollars-134000p" rel="alternate"></link><updated>2010-04-18T13:01:49Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:factsaboutmenopause.com,2010-04-18:/photo/pfizer-acquire-wyeth-68-billion-dollars-134000p/</id><summary type="html">epa01614571 &lt;a title="Jeffery Kindler" href="/topic/Jeffery+Kindler" &gt;Jeffery B. Kindler&lt;/a&gt;, Chairman and CEO of Pfizer (L) speaks as &lt;a title="Bernard Poussot" href="/topic/Bernard+Poussot" &gt;Bernard Poussot&lt;/a&gt;, Chairman and CEO of Wyeth listens at a press conference to announce that &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; will acquire Wyeth for approximately 8 billion dollars, at Pfizer headquarters in &lt;a title="New York" href="/topic/New+York" &gt;New York&lt;/a&gt;, &lt;a title="Un...</summary><category term="Company Activities and Information"></category><category term="Mergers and Acquisitions"></category><category term="Takeovers"></category><category term="Economic Issues"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Economic Crisis"></category><category term="United States"></category><category term="New York"></category><category term="Pfizer Inc."></category><category term="Bernard Poussot"></category><category term="BellSouth Corporation"></category><category term="Jeffery Kindler"></category></entry></feed>
